These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 28237728)

  • 1. Recognition of viral and self-antigens by T
    Paroni M; Maltese V; De Simone M; Ranzani V; Larghi P; Fenoglio C; Pietroboni AM; De Riz MA; Crosti MC; Maglie S; Moro M; Caprioli F; Rossi R; Rossetti G; Galimberti D; Pagani M; Scarpini E; Abrignani S; Geginat J
    J Allergy Clin Immunol; 2017 Sep; 140(3):797-808. PubMed ID: 28237728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention.
    van Langelaar J; van der Vuurst de Vries RM; Janssen M; Wierenga-Wolf AF; Spilt IM; Siepman TA; Dankers W; Verjans GMGM; de Vries HE; Lubberts E; Hintzen RQ; van Luijn MM
    Brain; 2018 May; 141(5):1334-1349. PubMed ID: 29659729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of TH17 cells in multiple sclerosis: Therapeutic implications.
    Moser T; Akgün K; Proschmann U; Sellner J; Ziemssen T
    Autoimmun Rev; 2020 Oct; 19(10):102647. PubMed ID: 32801039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of CD4+ CD8+ double-positive T cells in blood, cerebrospinal fluid and multiple sclerosis lesions.
    Waschbisch A; Sammet L; Schröder S; Lee DH; Barrantes-Freer A; Stadelmann C; Linker RA
    Clin Exp Immunol; 2014 Aug; 177(2):404-11. PubMed ID: 24730443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR6
    Restorick SM; Durant L; Kalra S; Hassan-Smith G; Rathbone E; Douglas MR; Curnow SJ
    Brain Behav Immun; 2017 Aug; 64():71-79. PubMed ID: 28336414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fingolimod modulates T cell phenotype and regulatory T cell plasticity in vivo.
    Dominguez-Villar M; Raddassi K; Danielsen AC; Guarnaccia J; Hafler DA
    J Autoimmun; 2019 Jan; 96():40-49. PubMed ID: 30122421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis.
    Brucklacher-Waldert V; Stuerner K; Kolster M; Wolthausen J; Tolosa E
    Brain; 2009 Dec; 132(Pt 12):3329-41. PubMed ID: 19933767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood T cell dynamics predict relapse in multiple sclerosis patients on fingolimod.
    Song ZY; Yamasaki R; Kawano Y; Sato S; Masaki K; Yoshimura S; Matsuse D; Murai H; Matsushita T; Kira J
    PLoS One; 2014; 10(4):e0124923. PubMed ID: 25919001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation.
    Darlington PJ; Touil T; Doucet JS; Gaucher D; Zeidan J; Gauchat D; Corsini R; Kim HJ; Duddy M; Jalili F; Arbour N; Kebir H; Chen J; Arnold DL; Bowman M; Antel J; Prat A; Freedman MS; Atkins H; Sekaly R; Cheynier R; Bar-Or A;
    Ann Neurol; 2013 Mar; 73(3):341-54. PubMed ID: 23463494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natalizumab Treatment Induces Proinflammatory CD4 T Cells Preferentially in the Integrin β7+ Compartment.
    Nguyen Ky M; Duran A; Hasantari I; Bru A; Deloire M; Brochet B; Ruet A; Schmitt N
    Neurol Neuroimmunol Neuroinflamm; 2023 Nov; 10(6):. PubMed ID: 37739811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.
    Stüve O; Marra CM; Bar-Or A; Niino M; Cravens PD; Cepok S; Frohman EM; Phillips JT; Arendt G; Jerome KR; Cook L; Grand'Maison F; Hemmer B; Monson NL; Racke MK
    Arch Neurol; 2006 Oct; 63(10):1383-7. PubMed ID: 17030653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study.
    Jilek S; Jaquiéry E; Hirsch HH; Lysandropoulos A; Canales M; Guignard L; Schluep M; Pantaleo G; Du Pasquier RA
    Lancet Neurol; 2010 Mar; 9(3):264-72. PubMed ID: 20117055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic interference with leukocyte recirculation in multiple sclerosis.
    Sellebjerg F; Sørensen PS
    Eur J Neurol; 2015 Mar; 22(3):434-42. PubMed ID: 25582213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients.
    Wu Q; Wang Q; Mao G; Dowling CA; Lundy SK; Mao-Draayer Y
    J Immunol; 2017 Apr; 198(8):3069-3080. PubMed ID: 28258191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin decreases the production of Th1/Th17 cytokines and elevates the frequency of regulatory CD4
    Sacramento PM; Monteiro C; Dias ASO; Kasahara TM; Ferreira TB; Hygino J; Wing AC; Andrade RM; Rueda F; Sales MC; Vasconcelos CC; Bento CAM
    Eur J Immunol; 2018 Aug; 48(8):1376-1388. PubMed ID: 29719048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
    Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
    Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune surveillance in multiple sclerosis patients treated with natalizumab.
    Stüve O; Marra CM; Jerome KR; Cook L; Cravens PD; Cepok S; Frohman EM; Phillips JT; Arendt G; Hemmer B; Monson NL; Racke MK
    Ann Neurol; 2006 May; 59(5):743-7. PubMed ID: 16634029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis.
    Darlington PJ; Stopnicki B; Touil T; Doucet JS; Fawaz L; Roberts ME; Boivin MN; Arbour N; Freedman MS; Atkins HL; Bar-Or A
    Front Immunol; 2018; 9():834. PubMed ID: 29867923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.